Literature DB >> 23345306

Commentary on 'Small-sample behavior of novel phase I cancer trial designs'.

Ying Kuen Cheung1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23345306     DOI： 10.1177/1740774512470221

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  2 in total

1.  The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRM.

Authors:  Joseph S Koopmeiners; Andrew Wey
Journal:  J Biopharm Stat       Date:  2017-03-25       Impact factor: 1.051

2.  Sample size formulae for the Bayesian continual reassessment method.

Authors:  Ying Kuen Cheung
Journal:  Clin Trials       Date:  2013-08-21       Impact factor: 2.486
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.